Dermatology News

BOSTON — Biosimilar competition in Europe has significantly decreased the cost of medication, and has not only increased biosimilar availability but also increased the market share of bio-originators for which there is no biosimilar, according to a speaker at the 2018 Interdisciplinary Autoimmune Summit.

BOSTON — Rheumatologists need to do more to better understand the unique burdens and frustrations experienced by patients with multiple immune-mediated inflammatory diseases, according to Lilly Stairs, head of patient advocacy for Clara Health and a board member at the American Autoimmune Related Diseases Association.

BOSTON — Advances in the understanding of epigenetic modifications — changes in gene activity without changes in DNA sequencing — could lead to the development of new biomarkers and potential therapies for immune-modulated inflammatory diseases, according to a presentation given at the Interdisciplinary Autoimmune Summit.

BOSTON — Rheumatologists, gastroenterologists, dermatologists, immunologists and other health care providers who care for patients with immune-mediated inflammatory diseases will gather at the Interdisciplinary Autoimmune Summit in Boston this weekend for a collaborative discussion of treatment strategies.

Primary care physicians are responsible for detecting and managing a wide variety of conditions, and for some patients, the PCP may be the only doctor they visit with regularity. Because early detection of serious skin conditions like melanoma is crucial to preventing its spread and possible mortality, PCPs can play an important role as the first clinician to see signs of this potentially deadly disease.

Married patients with melanoma appeared more likely to present with early-stage disease than divorced, widowed or never-married patients, according to findings published in JAMA Dermatology.

For the treatment of palmoplantar pustulosis resistant to conventional therapies, guselkumab appeared safe and effective, according to recent findings.

Recent findings revealed that adalimumab taken for hidradenitis suppurativa or psoriasis once weekly or every other week have similar safety and adverse event profiles

A single round of total community treatment with azithromycin in a subdistrict of Ghana endemic for yaws was effective in reducing the prevalence of this disease 12 months after treatment, according to study results published in PLoS Neglected Tropical Diseases.

Psoriasis of the scalp, face, intertriginous areas, genitals, hands, feet and nails are frequently underdiagnosed and undertreated, despite the severity of symptoms associated with these manifestations.